159 related articles for article (PubMed ID: 35038424)
21. The Anti-Trypanosoma cruzi activity of posaconazole in a murine model of acute Chagas' disease is less dependent on gamma interferon than that of benznidazole.
Ferraz ML; Gazzinelli RT; Alves RO; Urbina JA; Romanha AJ
Antimicrob Agents Chemother; 2007 Apr; 51(4):1359-64. PubMed ID: 17220408
[TBL] [Abstract][Full Text] [Related]
22. Molecular and biological characterization of a highly pathogenic Trypanosoma cruzi strain isolated from a patient with congenital infection.
Gulin JEN; Bisio M; Rocco DM; Altcheh J; Solana ME; García-Bournissen F
Exp Parasitol; 2018 Mar; 186():50-58. PubMed ID: 29448038
[TBL] [Abstract][Full Text] [Related]
23. Pharmacological potential of new metronidazole/eugenol/dihydroeugenol hybrids against Trypanosoma cruzi in vitro and in vivo.
Gonçalves-Santos E; Caldas IS; Fernandes VÂ; Franco LL; Pelozo MF; Feltrim F; Maciel JS; Machado JVC; Gonçalves RV; Novaes RD
Int Immunopharmacol; 2023 Aug; 121():110416. PubMed ID: 37295025
[TBL] [Abstract][Full Text] [Related]
24. CD8low T cells expanded following acute Trypanosoma cruzi infection and benznidazole treatment are a relevant subset of IFN-γ producers.
Marins-Dos-Santos A; Olivieri BP; Ferreira-Reis R; de Meis J; Silva AA; de Araújo-Jorge TC; Lannes-Vieira J; Cotta-de-Almeida V
PLoS Negl Trop Dis; 2020 Dec; 14(12):e0008969. PubMed ID: 33347472
[TBL] [Abstract][Full Text] [Related]
25. Assessment of a combined treatment with a therapeutic vaccine and benznidazole for the Trypanosoma cruzi chronic infection.
Prochetto E; Bontempi I; Rodeles L; Cabrera G; Vicco M; Cacik P; Pacini MF; Pérez Gianeselli M; Pérez AR; Marcipar I
Acta Trop; 2022 May; 229():106334. PubMed ID: 35101415
[TBL] [Abstract][Full Text] [Related]
26. Trypanosoma cruzi: effect of benznidazole therapy combined with the iron chelator desferrioxamine in infected mice.
Francisco AF; de Abreu Vieira PM; Arantes JM; Pedrosa ML; Martins HR; Silva M; Veloso VM; de Lana M; Bahia MT; Tafuri WL; Carneiro CM
Exp Parasitol; 2008 Dec; 120(4):314-9. PubMed ID: 18789321
[TBL] [Abstract][Full Text] [Related]
27. The β-blocker carvedilol and the benznidazole modulate the cardiac immune response in the acute infection induced by Colombian strain of the Trypanosoma cruzi.
Horta AL; Figueiredo VP; Leite ALJ; Costa GP; Menezes APJ; Ramos CO; Pedrosa TCF; Bezerra FS; Vieira PMA; Talvani A
Mem Inst Oswaldo Cruz; 2018 Oct; 113(11):e180271. PubMed ID: 30365644
[TBL] [Abstract][Full Text] [Related]
28. Nitric oxide donor trans-[RuCl([15]aneN)NO] as a possible therapeutic approach for Chagas' disease.
Guedes PM; Oliveira FS; Gutierrez FR; da Silva GK; Rodrigues GJ; Bendhack LM; Franco DW; Do Valle Matta MA; Zamboni DS; da Silva RS; Silva JS
Br J Pharmacol; 2010 May; 160(2):270-82. PubMed ID: 20128813
[TBL] [Abstract][Full Text] [Related]
29. Trypanosoma cruzi: Does the intake of nanoencapsulated benznidazole control acute infections?
Dutra da Silva A; Fracasso M; Bottari NB; Gundel S; Ourique AF; Assmann CE; Ferreira DASP; Castro MFV; Reichert KP; de Souza LAF; da Veiga ML; da Rocha MIUM; Monteiro SG; Morsch VM; Chitolina Schetinger MR; da Silva AS
Exp Parasitol; 2023 Jun; 249():108520. PubMed ID: 37001581
[TBL] [Abstract][Full Text] [Related]
30. An in vitro iron superoxide dismutase inhibitor decreases the parasitemia levels of Trypanosoma cruzi in BALB/c mouse model during acute phase.
Olmo F; Urbanová K; Rosales MJ; Martín-Escolano R; Sánchez-Moreno M; Marín C
Int J Parasitol Drugs Drug Resist; 2015 Dec; 5(3):110-6. PubMed ID: 26236582
[TBL] [Abstract][Full Text] [Related]
31. Benznidazole alters the pattern of Cyclophosphamide-induced reactivation in experimental Trypanosoma cruzi-dependent lineage infection.
Santos DM; Martins TA; Caldas IS; Diniz LF; Machado-Coelho GL; Carneiro CM; Oliveira Rde P; Talvani A; Lana M; Bahia MT
Acta Trop; 2010 Feb; 113(2):134-8. PubMed ID: 19854145
[TBL] [Abstract][Full Text] [Related]
32. The mitochondrial uncoupler 2,4-dinitrophenol modulates inflammatory and oxidative responses in Trypanosoma cruzi-induced acute myocarditis in mice.
Caetano-da-Silva JE; Gonçalves-Santos E; Domingues ELBC; Caldas IS; Lima GDA; Diniz LF; Gonçalves RV; Novaes RD
Cardiovasc Pathol; 2024 May; 72():107653. PubMed ID: 38740356
[TBL] [Abstract][Full Text] [Related]
33. Benznidazole therapy during acute phase of Chagas disease reduces parasite load but does not prevent chronic cardiac lesions.
Caldas IS; Talvani A; Caldas S; Carneiro CM; de Lana M; da Matta Guedes PM; Bahia MT
Parasitol Res; 2008 Jul; 103(2):413-21. PubMed ID: 18454349
[TBL] [Abstract][Full Text] [Related]
34. Impact of levamisole in co-administration with benznidazole on experimental Chagas disease.
Rocha Simões-Silva M; Brandão Peres R; Britto C; Machado Cascabulho C; de Melo Oliveira G; Nefertiti da Gama A; França da Silva C; Lima da Costa K; Finamore Araújo P; Diego de Souza Campos J; Meuser Batista M; Cristina Demarque K; da Cruz Moreira O; de Nazaré Correia Soeiro M
Parasitology; 2019 Jul; 146(8):1055-1062. PubMed ID: 31046850
[TBL] [Abstract][Full Text] [Related]
35. Decreased intensity of inflammation in benznidazole-treated mice inoculated with Trypanosoma cruzi I stocks from Mexico and persistence of circulating parasites.
Cruz-Zetina G; del Rio-Rodriguez R; Ramos-Ligonio A; López R; Monteon V
Am J Trop Med Hyg; 2012 Oct; 87(4):671-4. PubMed ID: 22890036
[TBL] [Abstract][Full Text] [Related]
36. Low-dose benznidazole treatment results in parasite clearance and attenuates heart inflammatory reaction in an experimental model of infection with a highly virulent Trypanosoma cruzi strain.
Cevey ÁC; Mirkin GA; Penas FN; Goren NB
Int J Parasitol Drugs Drug Resist; 2016 Apr; 6(1):12-22. PubMed ID: 26862474
[TBL] [Abstract][Full Text] [Related]
37. Canova medication modifies parasitological parameters in mice infected with Trypanosoma cruzi.
Pupulin AR; Marques-Araujo S; Toledo MJ; Gomes ML; Takejima E; Cuman RK; Bersani-Amado CA
Exp Parasitol; 2010 Dec; 126(4):435-40. PubMed ID: 20433834
[TBL] [Abstract][Full Text] [Related]
38. Schistosoma mansoni co-infection modulates Chagas disease development but does not impair the effect of benznidazole-based chemotherapy.
Lozano KJG; Gonçalves Santos E; Vilas Boas DF; Oliveira RRG; Diniz LF; Benedetti MD; Carneiro CM; C Bandeira L; Faria G; Gonçalves RV; Novaes RD; Caldas S; Caldas IS
Int Immunopharmacol; 2024 Feb; 128():111467. PubMed ID: 38211479
[TBL] [Abstract][Full Text] [Related]
39. The immunomodulatory effects of the Enalapril in combination with Benznidazole during acute and chronic phases of the experimental infection with Trypanosoma cruzi.
Leite ALJ; Paula Costa G; Lopes LR; Reis Mota LWD; Vieira PMA; Talvani A
Acta Trop; 2017 Oct; 174():136-145. PubMed ID: 28720491
[TBL] [Abstract][Full Text] [Related]
40. Interleukin-12 enhances in vivo parasiticidal effect of benznidazole during acute experimental infection with a naturally drug-resistant strain of Trypanosoma cruzi.
Michailowsky V; Murta SM; Carvalho-Oliveira L; Pereira ME; Ferreira LR; Brener Z; Romanha AJ; Gazzinelli RT
Antimicrob Agents Chemother; 1998 Oct; 42(10):2549-56. PubMed ID: 9756754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
